1Lakey D L, Treanor J, Betts R F, et al. Recombinant Baculivirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis, 1996,174:838-841.
2Robinson H L. Nucleic acid vaccines: an overview. Vaccine, 1997,15:785-787.
3Chen Z, Matsuok, Asanumah, et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin-and neuraminidase-expressing DNAs. Vaccine, 1999,17(7-8) :653-659.
4Levi R, Aboud-Pirok E A, Leclerc C, et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine, 1995,13:1353-1359.
5John J T, Robert F B,Gale E S,et al. Evaluation of a recombinant Hemagglutinin expressed in insect cells as an influenza yaccinc in young and elderly adults. J Infect Dis, 1996,174:1467-1470.
6Parkin N T, Chiu P, Coelingh K. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol, 1997,71: 2772-2778.
7Hilbert A K, McCarthy L, Mills K H. Biodegradable microspheres containing influenza a vaccine Immune response in mice. Vaccine, 1999,17:1065-1073.
8Robert B B. A review of attenuation of influenza virus by genetic manipulation. Am J Respir Crit Med, 1995,152:72-75.
9Arnon R , Levi R. Synthetic reconbinant vaccines against viral agents. Int Arch Allergy Immunol, 1995,108: 321-326.
10Harley V R, Mather K A,Power B E,et al. Characterization of an avian influenza virus nucleoprotein expressed in E. coli and in insect cells. Arch Virol, 1990,113: 267-277.
